Platinum quantum dots and their cytotoxic effect towards myoblast cancer cells (C 2C 12)

Journal of Biomedical Nanotechnology

Volumn 8, Issue 3, 2012, Pages 424-431

  Wahab, Rizwan ^a,b   Yang, YouBing ^a,c   Umar, Ahmad ^d   Singh, Surya ^e   Hwang, I H ^a   Shin, Hyung Shik ^a   Kim, Young Soon ^a  

^a Chonbuk National University   (South Korea)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d NAJRAN UNIVERSITY   (Saudi Arabia)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C 2C 12 myoblast cancer cells; MTT assay; Pt quantum dots

Indexed keywords

ANTI-CANCER AGENTS; CANCER CELLS; COLLOIDAL PROCESS; CYTOTOXIC EFFECTS; HIGH-DENSITY; HIGH-RESOLUTION TEM; INCUBATION INTERVALS; INCUBATION TIME; MTT ASSAYS; MYOBLASTS; TRANSMISSION ELECTRON MICROSCOPY TEM;

CELL DEATH; CYTOTOXICITY; SEMICONDUCTOR QUANTUM DOTS; TRANSMISSION ELECTRON MICROSCOPY;

PLATINUM;

ANTINEOPLASTIC AGENT; PLATINUM NANOPARTICLE; PLATINUM QUANTUM DOT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; COLLOID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; MYOBLAST; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOTOXINS; MATERIALS TESTING; MICE; MUSCLE NEOPLASMS; PLATINUM; QUANTUM DOTS;

EID: 84862282058     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1448     Document Type: Article

References (46)

1. H. S. Nalwa (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles (2004/2011), Vols. 1-25.
2. H. S. Nalwa (ed.), Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechnology, American Scientific Publishers, Los Angeles (2005), Vols. 1-2.
3. A. Umar and Y. B. Hahn (eds.), Metal Oxide Nanostructures and Their Applications, American Scientific Publishers, Los Angeles (2010), Vols. 1-5.
4. N. He and H. S. Nalwa (eds.), Biochips Nanotechnology, American Scientific Publishers, Los Angeles (2009).
5. H. S. Nalwa and T. Webster (eds.), Cancer Nanotechnology - Nanomaterials for Cancer Diagnosis and Therapy, American Scientific Publishers, Los Angeles (2007).
6. S. Singh, Nanomedicine-nanoscale drugs and delivery systems. J. Nanosci. Nanotechnol. 10, 7906 (2010).
7. (a) Y. L. Zhao and H. S. Nalwa (eds.), Nanotoxicology-Interactions of Nanomaterials with Biological Systems, American Scientific Publishers, Los Angeles (2007);
8. (b) S. Singh and H. S. Nalwa, Nanotechnology and health safety - toxicity and risk assessments of nanostructured materials on human health. J. Nanosci. Nanotechnol. 7, 3048 (2007).
9. (a) K. Y. Kim, Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine 2, 103 (2007);
10. (b) M. N. Rittner, Market analysis of nanostructured materials. Am. Ceram. Soc. Bull. 81, 33 (2002).
11. E. Oesterling, N. Chopra, V. Gavalas, X. Arzuag, E. J. Lim, R. Sultana, D. A. Butterfield, L. Bachas, and B. Hennig, Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicology Lett. 178, 160 (2008).
12. J. M. Laval, P. E. Mazeran, and D. Thomas, Nanobiotechnology and its role in the development of new analytical devices. Analyst 125, 29 (1999).
13. T. A. Desai, Micro- and nanoscale structures for tissue engineering constructs, Med. Eng. Phys. 22, 595 (2000).
14. L. A. Bauer, N. S. Birenbaum, and G. J. Meyer, Biological applications of high aspect ratio nanoparticles. J. Mater. Chem. 14, 517 (2004).
15. L. Mazzola, Commercializing nanotechnology. Nature Biotechnol. 21, 1137 (2003).
16. K. M. Reddy, K. Feris, J. Bell, D. G. Wingett, and C. Hanley, Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 90, 213902 (2007).
17. K. Jain, Personalised medicine for cancer: From drug development into clinical practice. Expert Opin. Pharmacother. 6, 1463 (2005).
18. W. J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Desai, P. Bhar, M. Hawkins, and J. O'Shaughnessy, Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J. Clin. Oncol. 23, 7794 (2005).
19. N. K. Ibrahim, B. Samuels, R. Page, D. Doval, K. M. Patel, S. C. Rao, M. K. Nair, P. Bhar, N. Desai, and G. N. Hoprtobagi, Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. J. Clin. Oncol. 23, 6019 (2005).
20. A. Anitha, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, 5-flourouracil loaded N, O -carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer. J. Biomed. Nanotechnol. 8, 29 (2012).
21. P. Liu, X. Qi, Y. Sun, H. Wang, Y. Li, and Y. Duan, RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast cancer xenografts. In Vivo. J. Nanosci. Nanotechnol. 11, 10760 (2011).
22. T. K. Mandal and N. Parvin, Rapid detection of bacteria by carbon quantum dots. J. Biomed. Nanotechnol. 7, 846 (2011).
23. K. C. Lee, C. Maturo, R. Rodriguez, H. L. Nguyen, and R. Shorr, Nanomedicine- nanoemulsion formulation improves safety and efficacy of the anti-cancer drug paclitaxel according to preclinical assessment. J. Nanosci. Nanotechnol. 11, 6642 (2011).
24. R. Singh and H. S. Nalwa, Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J. Biomed. Nanotechnol. 7, 489 (2011).
25. J. Aswathy, S. Jahnavi, R. Krishna, K. Manzoor, S. K. Nair, and D. Menon, Targeted labeling of cancer cells using biotin tagged avidin functionalized biocompatible fluorescent nanocrystals. J. Nanosci. Nanotechnol. 11, 7611 (2011).
26. K. W. Huang, S. Y. Yang, C. Y. Yu, J. J. Chieh, C. C. Yang, H. E. Horng, C. Y. Hong, H. C. Yang, and C. C. Wu, Exploration of the relationship between the tumor burden and the concentration of vascular endothelial growth factor in liver-cancer-bearing animals using immunomagnetic reduction assay. J. Biomed. Nanotechnol. 7, 535 (2011).
27. J. S. Lee, H. L. Rodríguez-Luccioni, J. Méndez, A. K. Sood, G. L. Berestein, C. Rinaldi, and M. T. Lugo, Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-diamminedi chloro platinum. J. Nanosci. Nanotechnol. 11, 4153 (2011).
28. J. W. Park, Liposome-based drug delivery in breast cancer treatment. Breast Cancer. Res. 4, 95 (2002).
29. N. Sanoj Rejinold, M. Muthunarayanan, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J. Biomed. Nanotechnol. 7, 521 (2011).
30. R. D. Hofheinz, S. U. Gnad-Vogt, U. Beyer, and A. Hochhaus, Liposomal encapsulated anti-cancer drugs. AnticancerDrugs 16, 691 (2005).
31. I. E. Palamà, A. M. L. Coluccia, A. della Torre, V. Vergaro, E. Perrone, R. Cingolani, R. Rinaldi, and S. Leporatti, Multilayered polyelectrolyte capsules and coated colloids: Cytotoxicity and uptake by cancer cells. Sci. Adv. Mater. 2, 138 (2010).
32. W. S. Hwang and S. J. Sim, A strategy for the ultrasensitive detection of cancer biomarkers based on the lspr response of a single AuNP. J. Nanosci. Nanotechnol. 11, 5651 (2011).
33. S. F. Shen, H. W. Zhao, D. Xu, L. P. Wu, and C. Z. Huang, Colorimetric assay of melamine based on the aggregation of gold nanoparticles. J. Biomed. Nanotechnol. 7, 691 (2011).
34. K.-D. Park, S. G. Lee, and M. S. Jeong, Epidermal growth factor receptor imaging of A431 cancer cells using gold nanorods, J. Nanosci. Nanotechnol. 11, 7053 (2011).
35. M. A. Syed and S. H. A. Bokhari, Gold nanoparticle based microbial detection and identification. J. Biomed. Nanotechnol. 7, 229 (2011).
36. M. Kajita, K. Hikosaka, M. Iitsuka, A. Kanayama, N. Toshima, and Y. Miyamoto, Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radicals Res. 41, 615 (2007).
37. A. Watanabe, M. Kajita, J. Kim, A. Kanayama, K. Takahashi, T. Mashino, and Y. Miyamoto. In vitro free radicals scavenging activity of platinum nanoparticles. Nanotechnology 20, 455105 (2009).
38. H. Gehrke, J. Pelka, C. G. Hartinger, H. Blank, F. Bleimund, R. Schneider, D. Gerthsen, S. Brase, M. Crone, M. Turk, and D. Marko, Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations. Arch. Toxicol. 85, 799 (2011).
39. Y. Yoshihisa, A. Honda, Q. L. Zhao, T. Makino, R. Abe, K. Matsui, H. Shimizu, Y. Miyamot, T. Kondo, and T. Shimizu, Protective effects of platinum nanoparticles against UV-light-induced epidermal inflammation. Exp. Dermatol. 19, 1000 (2010).
40. S. Onizawa, K. Aoshiba, M. Kajita, Y. Miyamoto, and A. Nagai, Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke. Pulmonary Pharmacol. Ther. 22, 340 (2009).
41. H. Kawasaki, M. Uota, T. Yoshimura, D. Fujikawa, G. Sakai, and T. Kijima, One-dimensional assemblies of platinum nanoparticles on a graphite surface using non ionic/ionized mixed hemicylindrical micelle templates. J. Colloid Interface Sci. 300, 149 (2006).
42. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Method 65, 55 (1983).
43. A. P. Singh, N. K. Kaushik, A. K. Verma, G. Hundal, and R. Gupta, Synthesis, structure and biological activity of copper(II) complexes of 4-(2-pyridylmethyl)-1,7 dimethyl-1,4,7-triazonane-2,6-dione and 4-(2-pyridylethyl)-1,7-dimethyl-1,4,7 triazonane-2,6-dione. Eur. J. Med. Chem. 44, 1607 (2009).
44. E. Chang, N. Thekkek, W. W. Yu, V. L. Colvin, and R. Drezek, Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 12, 1412 (2006).
45. L. K. Limbach, Y. Li, R. N. Grass, T. J. Brunner, M. A. Hintermann, M. Muller, D. Gunther, and W. J. Stark, Oxide nanoparticle uptake in human lung fibro blasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 39, 9370 (2005).
46. K. L. Henderson, I. B. Belden, and I. R. Coats, Mass balance of metolachlor in a grassed phytoremediation system. Environ. Sci. Technol. 41, 4084 (2007).